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Systems impact of zinc chelation by the
epipolythiodioxopiperazine dithiol gliotoxin in
Aspergillus fumigatus: a new direction in natural
product functionality†
Aliabbas A. Saleh, a Gary W. Jones, ab Frances C. Tinley,a Stephen F. Delaney,a
Sahar H. Alabbadi, a Keith Fenlon,a Sean Doyle *a and Rebecca A. Owens *a
The non-ribosomal peptide gliotoxin, which autoinduces its own biosynthesis, has potent anti-fungal
activity, especially in the combined absence of the gliotoxin oxidoreductase GliT and bis-thiomethyltransferase
GtmA. Dithiol gliotoxin (DTG) is a substrate for both of these enzymes. Herein we demonstrate that DTG
chelates Zn2+ (m/z 424.94), rapidly chelates Zn2+ from Zn(4-(2-pyridylazo)-resorcinol) (Zn(PAR)2) and also
inhibits a Zn2+-dependent alkaline phosphatase (AP). Zn2+ addition rescues AP function following
DTG-associated inhibition, and pre-incubation of DTG with Zn2+ completely protects AP activity. Zn2+
(1–50 mM) also significantly relieves the potent gliotoxin-mediated inhibition of Aspergillus fumigatus
DgliT::DgtmA (p o 0.05), which infers in vivo dithiol gliotoxin-mediated sequestration of free Zn2+ or
chelation from intracellular metalloenzymes as inhibitory mechanisms. Quantitative proteomic analysis
revealed that excess Zn2+ alters the effect of gliotoxin on A. fumigatus DgliT, with differential abundance
of secondary metabolism-associated proteins in the combinatorial condition. GtmA abundance increased
18.8 fold upon co-addition of gliotoxin and Zn2+ compared to gliotoxin alone, possibly to compensate
for disruption to GtmA activity, as seen in in vitro assays. Furthermore, DTG effected significant in vitro
aggregation of a number of protein classes, including Zn2+-dependent enzymes, while proteins were
protected from aggregation by pre-incubating DTG with Zn2+. We conclude that DTG can act in vivo as a
Zn2+ chelator, which can significantly impede A. fumigatus growth in the absence of GliT and GtmA.
Significance to metallomics
Dithiol gliotoxin is a near-terminal biosynthetic intermediate from the gliotoxin biosynthetic pathway in the human pathogen Aspergillus fumigatus. Chemically
reduced gliotoxin, dithiol gliotoxin (DTG), is revealed as a biological zinc chelator, and conversely, zinc can relieve the hitherto cryptic fungal autotoxicity of
DTG. There is a systems-wide impact of zinc chelation by DTG on the fungal proteome, and we suggest it is DTG, as opposed to gliotoxin, which chelates zinc
from metalloproteins. Since gliotoxin can be sequestered by both fungi and bacteria, our findings infer a new avenue to interfere with, and exploit, cellular zinc
homeostasis in microorganisms.
Introduction
Gliotoxin and holomycin are microbial natural products, which
are produced by fungal and bacterial spp., respectively (Fig. 1).1–3
Both are low molecular mass metabolites, and each contains a
disulphide bridge formed by the action of oxidoreductases,
namely GliT and HlmI, on the respective dithiol precursor
(Fig. 1).4–6 Disulphide bridge formation is essential for microbial
self-protection against these reactive dithiol intermediates, and is
a pre-requisite for the Major Facilitator Superfamily transporter
GliA-mediated secretion of gliotoxin by Aspergillus fumigatus.5–8
Both metabolites are also present as bis-thiomethylated forms,
and gliotoxin bis-thiomethyltransferase GtmA converts dithiol
gliotoxin (DTG) to bis-dethiobis(methylthio)gliotoxin (BmGT) in
A. fumigatus, whereas the origin of the cognate activity against
dithiol holomycin in Streptomyces clavuligeris is unknown (Fig. 1).9,10
Bernardo et al. have shown that upon uptake by eukaryotic cells,
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gliotoxin is chemically reduced to the dithiol form by intracellular
glutathione (GSH).11 Carberry et al. revealed significantly elevated
intracellular GSH in gliotoxin-sensitive A. fumigatus DgliT and that
Saccharomyces cerevisiae Dgsh1, deficient in intracellular GSH, was
resistant to exogenous gliotoxin.12 The epipolythiodioxopiperazine
(ETP) gliotoxin autoinduces its own biosynthesis by activating gli
biosynthetic gene cluster expression, and BmGT formation has been
shown to result in gli cluster attenuation in A. fumigatus, which
results in the repression of gliotoxin biosynthesis.9,13,14 Methylation
of dithiol holomycin has been proposed as a back-up plan for
self-protection, and Dolan et al. revealed that A. fumigatus
DgliT::DgtmA is significantly more sensitive to exogenous gliotoxin
than a gliT-deficient mutant.15 This suggests that the combined
absence of both self-protection and negative regulation of
DTG biosynthesis (or its intracellular presence) results in
potent growth retardation – the precise cause of which is
unknown.10,15
Gliotoxin, other ETPs and dithiolopyrrolones have been shown
to inhibit the activity of many enzymes, and functionality of
specific proteins.16–21 Several studies have demonstrated that the
disulphide moiety of gliotoxin is responsible for most of the
associated bioactivity of this molecule, whereas the S-methylated
BmGT molecule is relatively inactive.17,22 In general, reactivity of
gliotoxin towards protein thiols, damage from redox cycling, and
Zn2+ ejection have been proposed as the respective mechanisms
whereby protein functionality is altered. Interestingly, addition of
the reducing agent, L-dithiothreitol (DTT), significantly augmented
the inhibitory activity of gliotoxin towards farnesyltransferase, and
either DTT or GSH augmented gliotoxin-mediated inhibition of
equine alcohol dehydrogenase.16,17 Notably, neither of the afore-
mentioned studies posited DTG-mediated Zn2+ chelation from
either Zn2+-dependent enzyme as the inhibitory mechanism.
In combination, these observations led us to hypothesise
that, acting as a potent Zn2+ chelator, DTG (and not gliotoxin),
could exhibit an equivalent mechanism of action towards
Zn2+-dependent enzyme systems. Moreover, DTG interference
with Zn2+ availability or Zn2+-dependent enzyme activity in
A. fumigatus DgliT::DgtmA could be the basis for observed and
extreme growth retardation.15 However, it is also essential to
consider a mechanistic reciprocity between DTG and Zn2+.
Consequently, while DTG may chelate the cation and impede
Zn2+-mediated enzyme activities, excess or available metal ion
may provide protection against intracellular DTG. Indeed, zinc
salts have been successfully used to reverse ovine and bovine
facial eczema associated with exposure to fungal ETPs such as
sporidesmin A, a related disulphide-containing metabolite
secreted by Pithomyces chartarum.23 It is postulated that Zn2+
chelates formed with sporidesmin Amay attenuate its unwanted
biological eﬀects. Interestingly, Woodcock et al. presented mass
spectrometric evidence of Zn2+[sporidesmin] chelates, and
noted that Zn2+[gliotoxin] chelates, following NaBH4-mediated
reduction, also existed, namely [2gliotoxin + Zn]2, [2gliotoxin +
Zn + Na] and [gliotoxin + ZnCl] (m/z 427).24 These authors
speculated that that mono-ligands with halide coordination
were the preferable complex form, however corresponding mass
spectra and fragmentation patterns were not presented.
The ZafA transcriptional regulator, which can induce expression
of the Zn2+ transporters zrfA, zrfB and zrfC, regulates zinc
homeostasis in A. fumigatus and is essential for virulence.25–28
ZrfC is the key essential transporter which effects Zn2+ acquisition
by A. fumigatus, while ZrfA and ZrfB play accessory and non-
essential roles.26 Interestingly, transporter ZrfB (AFUA_2G03860)
was found to be significantly increased in abundance (log2-fold
increase: 1.31) in long-term A. fumigatus DgtmA cultures, which
suggests interplay between dysregulated gliotoxin biosynthesis and
Zn2+ homeostasis.29
Herein, for the first time we reveal DTG as a Zn2+ chelator
which can specifically and significantly inhibit Zn2+-dependent
metalloenzyme activity. Moreover, we demonstrate that Zn2+
significantly reverses the inhibitory eﬀects of gliotoxin on
A. fumigatus DgliT::DgtmA, which implicates intracellular Zn2+
chelation as a potential growth inhibitory strategy against this
pathogen.15 Significant proteomic remodelling in A. fumigatus
DgliT in response to gliotoxin versus Zn2+/gliotoxin exposure
further illuminates a hitherto unanticipated in vivo interaction
between DTG and Zn2+.
Methods
High resolution mass spectrometry detection of gliotoxin
complexed to Zn2+
Tris(2-carboxyethyl)phosphine hydrochloride (TCEP)-reduced
gliotoxin (DTG; 300 mM final) was mixed with ZnSO47H2O in
the presence of formic acid (0.1% (v/v)) to achieve 0.5, 1 and
3-fold molar equivalents of Zn2+ to DTG. Samples were passed
through 0.22 mm spin filters and directly injected onto a Thermo
Q-ExactiveMass spectrometer (5 ml min1). Assessment of DTG-Zn2+
Fig. 1 Unrelated microbial dithiol-containing compounds undergo equivalent
biotransformations, and appear to be co-substrates for two enzyme
functionalities. (A) In Aspergillus fumigatus, DTG is either oxidised to
gliotoxin via gliotoxin oxidoreductase GliT or bis-thiomethylated by gliotoxin
bis-thiomethyltransferase GtmA. (B) In Streptomyces clavuligeris, dithiol
holomycin undergoes oxidoreductase HlmI-mediated conversion to
holomycin. The enzyme which catalyses S,S0-dimethyl holomycin formation
remains to be identified.
Paper Metallomics
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 0
6 
Ju
ne
 2
01
8.
 D
ow
nl
oa
de
d 
on
 7
/1
6/
20
18
 1
0:
38
:4
3 
A
M
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n-
N
on
Co
m
m
er
ci
al
 3
.0
 U
np
or
te
d 
Li
ce
nc
e.
View Article Online
856 | Metallomics, 2018, 10, 854--866 This journal is©The Royal Society of Chemistry 2018
complex formation was evaluated by both positive and negative
ESI mode with full MS scan (50–2000.00). The following settings
were used in the analysis: spray voltage (negative mode: 3.6 kV,
positive mode 4 kV), capillary temperature 320 1C.
Assessment of in vitro Zn2+ chelation by DTG
Zinc binding assays were performed as described in Chan et al.
with some modifications.30 Titrations were carried out in PBS
pH 7.4 (1 ml final volume). 4-(2-Pyridylazo)-resorcinol (PAR)
(80 ml; 1.5 mM) was added with 60 ml 1 mM ZnSO4, per ml to
yield final ratio of 2 : 1 (PAR : Zn2+). DTG (2.5 mM in methanol)
was prepared by 60 min pre-incubation with 12.5 mM TCEP in
100 ml final volume and was then added in increasing concentration
to yield 1, 2, 3, 4 and 5 molar equivalents of DTG to Zn(PAR)2
(final concentrations: 60 mM Zn2+, 120 mM PAR, 60–300 mM
DTG). 12.5 mM TCEP in methanol and oxidised gliotoxin
(2.5 mM) were used as negative controls. After addition of
all components, absorbance spectra were recorded between
200–800 nm.
Alkaline phosphatase (AP) and GtmA enzyme assays
Zn2+-Dependent AP from bovine intestinal mucosa (AP; 1.44 Uml1
(Sigma-Aldrich)) in PBS was pre-incubated with the following agents
to determine the extent of enzyme inhibition: 5 mM EDTA, 150 mM
gliotoxin (GT), 10–150 mM DTG (TCEP-reduced GT), 50 mM TPEN
(N,N,N0,N0-tetrakis(2-pyridylmethyl)ethane-1,2-diamine), 50 mM–5mM
DTT, or 50 mM–5 mM GSH for 15 min in triplicate. Control or
treated AP (50 ml per reaction) was added to 1 ml p-nitrophenol
phosphate (pNPP) (5 mM; dissolved in PBS with 50 mM glycine
pH 9.5) and assayed in triplicate at 37 1C for 30 min. Enzyme
reactions were terminated by addition of 20 mM NaOH (5 ml).
AP activity was determined by p-nitrophenol (pNP) detection at
405 nm following pNPP hydrolysis. The protective effect of pre-
incubating DTG or TPEN with Zn2+ was also evaluated using this
assay system. DTG (50 mM) or TPEN (50 mM) were pre-incubated
with Zn2+ (25–100 mM) for 15 min prior to addition of AP enzyme
and the rest of the assay was performed as before. To test the
capacity of Zn2+ to rescue DTP-associated loss of AP activity,
AP was pre-incubated with DTG (50 mM) for 15 min, followed
by addition of Zn2+ (0.1–1 mM) for a further 15 min, prior to
addition of pNPP substrate.
GtmA activity was determined as described in Dolan et al. to
evaluate the eﬀect of Zn2+ (molar ratio 0.0001–10 Zn2+ : 1 DTG)
on the formation of BmGT.15 Briefly, S-adenosylmethionine
(SAM) (1 mM final) and TCEP-reduced gliotoxin (250 mM final)
were combined, along with PBS. Zn2+ was added at a range of
concentrations (0.025, 0.25, 2.5, 25, 125, 250 mM and 2.5 mM),
representing a molar ratio ranging from 0.0001 to 10 : 1 Zn2+ :
DTG. A control was also prepared with no Zn2+ added. GtmA
(0.5 mM) was added to the mixture followed by incubation at
37 1C for 5 min. Reactions were stopped by protein precipitation
using TCA (final 15%) and incubation on ice for 20 min. Clarified
mixtures were analysed by RP-HPLC and absorbance monitored at
254 nm to determine the concentration of BmGT andmonomethyl
gliotoxin (MmGT).
Assessment of the eﬀect of Zn2+ on alkylation of DTG
Iodoacetamide (IAA) was used as an alkylating agent to investigate
the eﬀect of Zn2+ on alkylation of DTG. IAA stock (50 mM) was
prepared in 50 mM ammonium bicarbonate. 3 mM DTG was
prepared by 60 min pre-incubation of gliotoxin with 12.5 mM
TCEP. DTG (0.3 mM final) was mixed with ZnSO4 at a range of
concentrations (0.1, 0.15, 0.3, 0.6, 0.9 mM) to achieve molar
equivalents of Zn2+ to DTG of 0.33, 0.5, 1, 2 and 3, respectively.
IAA was subsequently added at a final concentration of 3 mM
(ratio IAA :DTG 10 : 1) and incubated in the dark for 20 min. All
reactions were carried out in methanol at 100 ml final volume.
Control samples were included to measure levels of DTG and
alkylated gliotoxin formed in the absence of Zn2+. Reactions were
evaluated by RP-HPLC.15
A. fumigatus phenotypic assays
A. fumigatus DgliT and DgliT::DgtmA strains were grown on MEA
agar for 5 days at 37 1C. After incubation, conidia were harvested
with PBST and washed three times with PBS and resuspended in
PBS. Conidia were counted using haemocytometer and stored at
4 1C for future use. Conidia were serially diluted to 103 ml1 and
5 ml was spotted on Czapek-Dox agar plates (permissive for
endogenous gliotoxin biosynthesis7) containing gliotoxin (0,
15 or 30 mM) and Zn2+, respectively. Plates were then incubated
at 37 1C and growth monitored up to 96 h by measuring radial
growth (mm) of each colony. Two-way ANOVA analysis was
performed to determine the statistical significance between
strains at diﬀerent concentrations of gliotoxin and Zn2+.
Extraction and measurement of extracellular and intracellular
gliotoxin
A. fumigatus wild-type and DgliT::DgtmA were grown in Sabouraud-
dextrose media for 21 h and gliotoxin was subsequently added for
3 h at 15 mM with and without Zn2+ (n = 3 biological replicates for
all specimens). Zn2+ was added at 1 mM final concentration.
Supernatant samples were taken after 15, 30, 60, 120 and 180 min
and were extracted using chloroform (1 :1), as described.31 The
organic extracts were subsequently dried down and resuspended in
methanol and analysed for gliotoxin content using RP-HPLC with
UV detection (Shimadzu), using polar C18 RP-HPLC column
(Phenomenex polar C18 Luna Omega column (150 mm 
4.6 mm, 5 mm)) at a flow rate of 1 ml min1. A mobile phase
of acetonitrile and water with 0.1% (v/v) TFA was used under
gradient conditions. A. fumigatus wild-type was also grown in
Czapek-Dox media for 72 h (gliotoxin-producing conditions) in
the presence of either low (0.027 mM) or high (0.5 mM) Zn2+ (n = 3
biological replicates for all specimens). Controls were included, with
no Zn2+ added. Aliquots were taken every 24 h and organic
extractions and RP-HPLC analyses were performed as outlined
above. For intracellular gliotoxin recovery, mycelia collected
after 3 h incubation were harvested and snap frozen in liquid
N2. Intracellular gliotoxin was extracted as described previously
for SAM, using a modified protocol.8 Briefly, mycelia were
ground using liquid N2 with a mortar and pestle. 100 mg
mycelia were incubated with 0.1 N HCl (250 ml) on ice for 1 h
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with intermittent vortexing. Protein was removed by addition of
100% TCA to achieve a final concentration of 15% (v/v) TCA.
After centrifugation at 16 000  g, supernatants were collected
and then analysed by RP-HPLC.
Proteomic analysis of gliotoxin aﬀects, with and without Zn2+,
on A. fumigatus DgliT
A. fumigatus DgliT was cultured (n = 3/condition) for 21 h in
Sabouraud-dextrose media (SDM) followed by addition of glio-
toxin (15 mM) or methanol (control) with and without ZnSO4
(1 mM) addition for 3 h. Mycelia were then harvested and snap
frozen in liquid N2. Mycelia were lysed using buﬀer (100 mM
Tris–HCl, 50 mM NaCl, 20 mM EDTA, 10% v/v glycerol. 1 mM
PMSF, 1 mg ml1 pepstatin A, pH 7.5) with grinding and
sonication, and clarified using centrifugation.8 The protein
lysates were then subjected to precipitation using TCA/acetone
and resuspended in 100 mM Tris–HCl, 6 M urea, 2 M thiourea,
pH 8.0. Samples were then reduced by DTT and followed by
alkylation using IAA. This was followed by addition of sequencing
grade trypsin combined with Protease Max surfactant for over-
night digestion. Following sample clean-up using Millipore C18
ZipTips, all peptide mixtures were analysed via a Thermo-Fisher
Q-Exactive mass spectrometer coupled to a Dionex RSLCnano.32
LC gradients ran from 4% to 35% ACN over 2 h, and data were
collected using a Top15 method for MS/MS scans. Comparative
proteome abundance and data analysis was performed using
MaxQuant software (v. 1.5.3.30), with PERSEUS used to organize
data (v. 1.5.4.0).33,34 Proteins with significant changes in abun-
dance (po 0.05; fold changeZ2) signified quantitative changes
between the sample treatments. Qualitative differences were also
noted, where proteins were not detected in one group and were
present in at least 2 replicates from the comparator group.
Functional analysis was carried out using FungiFun2 (https://
elbe.hki-jena.de/fungifun/fungifun.php).35
In vitro DTG induced-protein aggregation assays
Protein extracts were prepared from A. fumigatus mycelia from
three biological replicates, previously cultured in SDM at 37 1C,
for 24 h at 200 rpm. Mycelia were harvested by filtering through
Miracloth, snap-frozen and ground in liquid N2 using a pestle
and mortar. Lysis buﬀer (0.1 M Tris–HCl, 50 mM NaCl, 1 mM
PMSF pH 7.5; 400 ml) was added to ground mycelia (200 mg)
and lysed by sonication. Lysates were clarified by centrifugation
at 12 000g, 4 1C for 10 min and this was repeated twice to
remove insoluble material. Lysates were diluted to 1 mgml1 and
subjected to the following treatments in triplicate: (a) control:
methanol and TCEP were added as a solvent control; (b) DTG:
TCEP-reduced gliotoxin was added to the protein extracts to a
final concentration of 150 mM and (c) DTG/Zn2+:TCEP-reduced
gliotoxin was pre-mixed with ZnSO47H2O at a 1 : 3 molar ratio.
The mixture was added to the protein extracts in triplicate to
achieve a final concentration of 150 mM DTG and 450 mM Zn2+.
All samples were incubated at 50 1C for 30 min prior to addition
of solubilisation buffer and analysis by SDS-PAGE. Protein
aggregates were observed as a band of Coomassie-stained
protein at the interface between the stacking and resolving
gels. These bands were excised and subjected to in-gel digestion
according to Shevchenko et al.36 Peptide mixtures were de-salted
using C18 Zip-tips and analysed using Label-free quantitative
proteomics (Thermo Q-Exactive LC-MS). Data analysis was per-
formed using MaxQuant with Perseus for data organisation and
statistical analysis.9,32
Results
DTG chelates Zn2+ in vitro
High resolution mass spectrometry, spectrophotometry, and
chemical and enzyme assays were used to investigate the
formation of a complex between DTG and Zn2+. Following
TCEP-mediated reduction of gliotoxin and Zn2+ addition, negative
mode MS analysis revealed the presence of a Zn[dithiolate
gliotoxin] complex with m/z = 424.93851, corresponding to a
Cl adduct of the metal chelate (Fig. 2A and Fig. S1, ESI†).
Furthermore, DTG also competitively dissociated Zn2+ from a
Zn[(4-(2-pyridylazo)-resorcinol)2] Zn(PAR)2 complex, whereby
DTG (60–300 mM) addition resulted in a corresponding decrease
in A493nm of Zn(PAR)2, corresponding to Zn
2+ chelation (Fig. 2B).
Relevantly, gliotoxin had no effect on Zn(PAR)2 interaction
which confirmed the specific role of the dithiol moiety of
reduced gliotoxin in chelation (Fig. S2, ESI†). To investigate
the effect of Zn2+ on the enzymatic S-methylation of DTG, a
GtmA activity assay was performed. GtmA bis-thiomethylates
DTG to form BmGT using SAM as the methyl source (Fig. 1).9
Gliotoxin S-methylation occurs in a sequential manner, with
mono-methylated species (MmGT) appearing initially, followed
by formation of BmGT.9,15,37 Zn2+ inhibits GtmA-mediated thio-
methylation of gliotoxin in vitro in a concentration-dependent
manner, most likely due to an inability to recognise and bind
Zn2+[DTG] (Fig. 2C). Support for DTG thiol protection by Zn2+
coordination was provided by an alkylation assay. Although IAA
modifies DTG to alkylated gliotoxin, Zn2+ also inhibits alkylation of
DTG which further strengthens the concept of thiol occlusion via
Zn2+ chelation (Fig. 2D and Fig. S3, ESI†).
DTG inhibits AP by Zn2+ chelation
To investigate the ability of DTG to inhibit the activity of a zinc-
dependent metalloenzyme, AP activity assays were carried out.
Gliotoxin was reduced to DTG as described above and confirmed
by RP-HPLC (data not shown). DTG inhibited AP in a dose-
dependent manner (0–150 mM DTG) and time-dependent manner
(Fig. 3A and Fig. S4, ESI†). Solvent controls (containing TCEP and
methanol) did not show any significant AP inhibition. While
50 mM DTG significantly inhibited AP activity (p o 0.001), pre-
incubation of DTG (50 mM) with Zn2+ (25 mM–1 mM) alleviated
DTG-associated AP inhibition (Fig. 3B). The Zn2+ chelator TPEN
was also tested, but only produced a minor decrease in AP activity
(11%) when used at the same concentration as DTG (50 mM)
(Fig. 3C). EDTA (5 mM), a metal ion chelator, inhibited AP activity
by approx. 30–40% (Fig. S5, ESI†). AP activity was not significantly
inhibited by 150 mM GT, 50 mM–5 mM of the cellular reductant
GSH or 50 mM–1 mM of the thiol-containing reductant DTT
(Fig. S5, ESI†). Lack of inhibition by GT, TCEP, GSH or DTT
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strongly infers that inhibition is not caused by AP disulphide
bridge cleavage or thiol modification. Zinc addition for 30 min
reverses DTG-induced inhibition of AP, which further implicates
Zn2+ chelation as the mechanism of inhibition (Fig. S6, ESI†).
Fig. 2 Characterisation of DTG as a Zn2+ chelator. (A) Dithiolate gliotoxin complexed with Zn2+ (Cl adduct) with accompanying isotopic analysis in negative
ion mode MS (direct injection). Structure of DTG:Zn complex is depicted with positioning of the metal ion between the two thiolates, although exact
coordination with other groups is unknown. (B) DTG chelates Zn2+ from Zn(PAR)2 (Zn(PAR)2 pKd = 12.15)
44 in a concentration-dependent manner. Overlaid
UV-vis profiles of PAR alone (I; red), and Zn(PAR)2 (II; blue). DTG added in increased concentration to Zn(PAR)2 1–5 molar equivalents of oxidised gliotoxin to
Zn2+; III–VII, respectively. Decrease in A493nm is accompanied by increase in A413nm as free PAR is released. (C) Zn
2+ inhibits GtmA-mediated methylation of
DTG in a concentration dependent manner. Zn2+ was included in the methylation assay at a molar ratio ranging from 0.0001 to 10 : 1 (DTG). A control
containing no Zn2+ was included. Concentration (mM) of BmGT and MmGT formed after 5 min was determined by RP-HPLC. (D) Zn2+ inhibits IAA-mediated
alkylation of DTG in a concentration-dependent manner. RP-HPLC analysis (detection at 254 nm) reveals the inhibitory effect of Zn2+ on DTG alkylation.
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Impact of Zn2+ exposure on A. fumigatus DgliT and
DgliT::DgtmA, in the presence of exogenous gliotoxin
In order to determine whether Zn2+ had an impact on gliotoxin-
associated growth inhibition, plate assays were carried out
using A. fumigatus strains deficient in enzymes that use DTG
as their substrate, DgliT::DgtmA and DgliT. Severe radial growth
inhibition of A. fumigatus DgliT::DgtmA in the presence of
gliotoxin (15 mM)15 (Fig. 4A) was significantly relieved ( p o
0.005) in the presence of 1–10 mM Zn2+, and relief of gliotoxin-
mediated growth inhibition was maintained up to 50 mM Zn2+.
Radial growth of A. fumigatus DgliT::DgtmA was unaffected by
Zn2+ (1–50 mM). Higher concentrations of Zn2+ significantly
inhibited the growth of both A. fumigatus DgliT::DgtmA (100 mM–1
mM; Fig. 4) and A. fumigatus DgliT (1–2 mM; Fig. S7, ESI†). This
correlates with a decrease in the rescue effect of Zn2+ on gliotoxin-
associated growth inhibition in A. fumigatus DgliT::DgtmA. The
combination of gliotoxin (15–30 mM) and excess Zn2+ (1–2 mM)
produced further inhibition of radial growth of A. fumigatus DgliT
at 96 h (po 0.005) compared to the growth reduction observed in
either the presence of Zn2+ or gliotoxin alone (Fig. S7, ESI†).
Zn2+ augments gliotoxin uptake and eﬄux in A. fumigatus
wild-type and DgliT::DgtmA
Previous studies have revealed that exogenous gliotoxin is
sequestered by A. fumigatus.38 To further explore the interaction
between Zn2+ and gliotoxin in vivo, both A. fumigatus wild-type
and DgliT::DgtmA were exposed to gliotoxin (15 mM) for 3 h in
the presence and absence of Zn2+ (1 mM). In all conditions
uptake of gliotoxin by A. fumigatus was evident by decreasing
levels detected in culture supernatants across the incubation
times, and corresponding increases in intracellular gliotoxin
concentration (Fig. S8, ESI†). Fig. S8A–D (ESI†) show that excess
Zn2+ augmented gliotoxin uptake in both A. fumigatus wild-type
and DgliT::DgtmA. In the presence of Zn2+ (1 mM), with significantly
less gliotoxin detected in A. fumigatus wild-type culture supernatants
30 min after addition (Fig. S8A–C; p o 0.05, ESI†). Zn2+ effected a
more marked response in A. fumigatus DgliT::DgtmA, with a
significant decrease in extracellular gliotoxin levels at every time
point (15–180 min; Fig. S8B; p o0.05, ESI†). When excess Zn2+
was present in the culture medium, initial rates of gliotoxin
uptake increased from 38.32  5 to 55.04  8.78 ng min1 ml1
of culture (mean  SEM) in A. fumigatus wild-type and from
5.06 7.16 to 75.94 7.38 ngmin1 ml1 of culture (mean SEM)
Fig. 3 DTG inhibits AP activity by Zn2+ chelation. (A) Dose-dependent
(10–150 mM DTG) inhibition of AP activity, with IC50 = 38 mM DTG. Neither
GT or the solvent control (12.5 mM TCEP in methanol) inhibit AP activity.
(B) Pre-incubation of DTG with Zn2+ (0.1, 0.5 and 1 mM) prevents DTG-
mediated enzyme inhibition. (C) TPEN (50 mM) has no significant impact on
AP activity (89% activity compared to control). Pre-incubation of DTG with
Zn2+ (25–50 mM) significantly recovered AP activity to 86% of the control.
Fig. 4 (A) Potent growth inhibitory eﬀect of gliotoxin (15 mM) on A. fumigatus
DgliT::DgtmA is significantly (p o 0.005) reversed by co-addition of Zn2+
(1–50 mM). Zn2+ (0–50 mM) has a negligible effect on mutant growth.
(B) Graphical representation of same in terms of relative growth percentages.
Note that higher Zn2+ levels (100 mM–1 mM) result in dissipation of the relief,
in line with Zn2+-associated toxicity noted in controls.
Paper Metallomics
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 0
6 
Ju
ne
 2
01
8.
 D
ow
nl
oa
de
d 
on
 7
/1
6/
20
18
 1
0:
38
:4
3 
A
M
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n-
N
on
Co
m
m
er
ci
al
 3
.0
 U
np
or
te
d 
Li
ce
nc
e.
View Article Online
860 | Metallomics, 2018, 10, 854--866 This journal is©The Royal Society of Chemistry 2018
in DgliT::DgtmA. Commensurate increases in intracellular gliotoxin
(ng/100 mg mycelia) were observed in both A. fumigatus wild-
type and DgliT::DgtmA, in the presence of Zn2+ (Fig. S8D, ESI†).
Intracellular levels of gliotoxin were significantly increased in A.
fumigatus wild-type upon Zn2+ co-addition (po 0.01), likely due
to inhibition of GtmA-catalysed BmGT formation and efflux.
Elevated intracellular gliotoxin levels in DgliT::DgtmA correlated
with an increased rate of gliotoxin uptake induced by Zn2+ (Fig. S8,
ESI†). Intracellular DTG was not detectable due to either spon-
taneous intracellular or extraction-associated oxidation.
LFQ proteomic analysis reveals that Zn2+ alters the eﬀect of
gliotoxin on A. fumigatus DgliT
To further investigate the nature of the combinatorial inhibition
of A. fumigatus DgliT during simultaneous exposure to Zn2+ and
gliotoxin, compared to gliotoxin alone, comparative LFQ pro-
teomic analysis was carried out. Overall, 47 proteins exhibited
unique presence and 23 proteins were significantly increased in
abundance in A. fumigatus DgliT upon combinatorial exposure
(Zn2+/GT) compared to gliotoxin only (Table S1, ESI†). Conversely,
45 proteins were absent and 10 proteins showed significantly
reduced abundance in A. fumigatus DgliT upon combinatorial
exposure compared to gliotoxin only (Table S1, ESI†). Functional
analysis revealed that zinc-ion binding proteins were significantly
enriched (8/70 proteins; p = 0.005) among proteins with elevated
abundance or uniquely detected in the presence of Zn2+/GT
compared to gliotoxin alone (Table 1 and Fig. S9, ESI†). Notably,
secondary metabolism-associated proteins were altered in abun-
dance, or demonstrated qualitative changes in the combined con-
dition (Zn2+/GT) compared to gliotoxin only (Table 2). These
included the ferricrocin synthetase SidC, which was repressed by
gliotoxin, but not by the combined condition, as were fourmembers
of the fumagillin biosynthetic cluster (Table 2 and Table S1, ESI†).
Consequently, when A. fumigatus was grown in gliotoxin-producing
conditions, Zn2+ caused a significant increase in fumagillin levels
even at lower levels (0.027 mM Zn2+; po 0.001) (Fig. S10, ESI†).
Low aﬃnity zinc transporter ZrfB, which is ZafA-dependent
and normally induced by zinc depletion, was undetectable in
the combinatorial exposure condition, which suggests a zinc-
limiting environment in gliotoxin-only exposure (Table 1). Like-
wise, allergen AspF2 which is expressed under zinc-limiting
conditions, and shares a divergent promoter with zrfC, was
absent upon co-exposure.39 It was also observed that GliM, a
component of the gliotoxin biosynthetic capacity was absent,
which infers that gliotoxin biosynthesis may be attenuated in
the combinatorial exposure scenario (Table 2). Indeed, Zn2+
presence completely abrogated gliotoxin biosynthesis in Czapek-
Dox media (Fig. S10, ESI†). These observations pertaining to
impeded gliotoxin biosynthesis are further supported by the
absence of GpgA (AFUA_1G05210), a G-protein coupled receptor
subunit, previously shown to be essential for gliotoxin production
in A. fumigatus.40 It is also notable that the nonribosomal peptide
synthetase NRPS8/Pes341 (AFUA_5G12730) was absent following
co-exposure to Zn2+ and gliotoxin, which suggests that it may
contribute to adaptation to zinc-limiting conditions.
Gliotoxin exposure induces elevated GtmA abundance in
A. fumigatus DgliT,9 and Manzanares-Miralles et al. reported
that gliotoxin induces significantly increased abundance of the
GtmA ortholog in Aspergillus niger, in which the gli cluster is
absent.37 Interestingly, while Zn2+ exposure alone had no sig-
nificant eﬀect on the abundance of GtmA in A. fumigatus,
combinatorial exposure with gliotoxin resulted in significantly
elevated GtmA abundance (18.8-fold and po 0.01) compared to
that in the presence of gliotoxin only (Table 2). Allied to GtmA
activity data (Fig. 2C), this suggests that in vivo chelation of Zn2+
by DTG may prevent substrate access to GtmA, thereby result-
ing in a further increased abundance of the enzyme (Fig. 5A).
Manifestation of heat-induced in vitro protein aggregation in
A. fumigatus mycelial lysates, specifically by DTG
Inhibition of Zn2+-dependent enzyme activities, combined with
the observed in vivo interplay between the divalent metal cation
Table 1 Zinc associated proteins with diﬀerential abundance, or uniquely detected, between the combination condition (Zn2+/GT) and the gliotoxin –
only control
Protein description Log2 fold change
a (p value) Uniquely detectedb Peptides Gene IDs (AFUA_)
Zinc ion binding
Zinc knuckle domain protein (Byr3), putative 1.33 (0.021) 9 1G07630
Rho GTPase activator activity Rga N/A Zn2+/GT 4 1G12680
Putative zinc-binding dehydrogenase family oxidoreductase 1.55 (0.0018) 16 1G15610
Putative formaldehyde dehydrogenase 1.54 (0.0027) 15 2G01040
Putative carbonic anhydrase CafA 1.65 (0.0029) 12 4G11250
C-x8-C-x5-C-x3-H type zinc finger N/A Zn2+/GT 5 4G13910
Putative zinc-dependent alcohol dehydrogenase AlcC 1.62 (0.0004) 30 5G06240
Cytidine deaminase, zinc ion binding activity N/A Zn2+/GT 2 7G01040
Zinc knuckle nucleic acid binding protein, putative N/A GT 2 7G02190
Putative carbonate dehydratase, zinc ion binding activity 1.67 (0.0041) 7 8G06554
Zinc homeostasis
Low aﬃnity plasma membrane zinc transporter ZrfB N/A GT 3 2G03860
Allergen Aspf2 Aspf2 N/A GT 7 4G09580
a Negative values indicate protein was decreased in abundance in combination treatment (Zn2+/GT) compared to the gliotoxin only treatment,
while positive values indicate an increase in abundance. b Uniquely detected: protein uniquely identified in at least 2 biological replicates of either
gliotoxin-only treated cultures or the combination condition (Zn2+/GT).
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and DTG in A. fumigatus, led us to further investigate the inter-
action between DTG and A. fumigatus proteins. DTG-associated
protein destabilisation was investigated by exposing complex
lysates to either DTG or a mixture of Zn2+ and DTG, followed by
heat treatment. Exposure of A. fumigatusmycelial protein lysates to
TCEP/methanol, DTG or a mixture of Zn2+ and DTG followed by
SDS-PAGE analysis revealed near-identical electrophoretic patterns
in the resolving gel (Fig. 5B). However, uniquely, following protein
lysate exposure to DTG, and subsequent heat treatment
(50 1C/30 min), either protein aggregation or an inability to
disaggregate unfolded proteins was observed (Fig. 5B). Mass
spectrometry-based analysis of the proteins retained at the
interface between the stacking and resolving gel identified
551 proteins in total from the three conditions tested. Label-free
proteomics revealed 94 proteins uniquely detected or significantly
elevated in the aggregates following DTG pre-treatment, relative to
the control (Fig. 5C and Table S2, ESI†). DTG addition to
A. fumigatus lysates elicits an overall increase in aggregated pro-
teins compared to the controls. Functional analysis revealed a
significant number of proteins with oxidoreductase activity
(n = 27, p = 0.019), metal ion binding (n = 16, p = 0.024) and
zinc ion binding (n = 7, p = 0.047) showed increased aggregation
in response to DTG treatment (Fig. 5D). Notably, pre-incubation
of DTG with Zn2+ prevented this aggregation in the case of 77%
of the DTG-responsive proteins (72/94 proteins), whereby the
combinatorial condition lead to significantly lower levels of
protein aggregation compared to DTG treatment (p o 0.05).
Additional stabilisationwas observed in the combinatorial condition,
as 77 proteins showed lower abundance in the aggregates compared
to the control condition (Fig. 5C). Excess Zn2+ used in the pre-mixed
DTG/Zn2+ treatment could contribute to this additional stabilising
eﬀect.
Among the proteins aﬀected by DTG-induced aggregation,
was the zinc-dependent alcohol dehydrogenase AlcC, which
was only detected in aggregates from lysates pre-incubated with
DTG, indicating co-addition of Zn2+ prevented DTG-induced
aggregation of this protein. Another protein detected exclusively in
aggregates induced by DTG was the putative farnesyltransferase
beta subunit Ram1 (AFUA_4G10330) which contains a C-terminal
Zn2+ binding pocket, within the active site.42,43 A number metallo-
peptidases were also increased or uniquely detected in DTG-
induced aggregates (AFUA_6G09190, AFUA_4G07910, MepB), as
well as the zinc-dependent methionine synthase MetH/D, while
co-addition of Zn2+ generated aggregation profiles in line with
the control.
Overall, these data suggest that DTG may chelate Zn2+ from
selected cellular proteins thereby inducing protein unfolding
and consequently resulting in temperature-induced aggregation. It
is also possible that DTG inhibits selected components of the
proteasome-mediated recognition and/or digestion of protein
aggregates; which results in their persistence in DTG-treated
Table 2 Secondary metabolism-related proteins with diﬀerential abundance, or uniquely detected, between the combination condition (Zn2+/GT) and
the gliotoxin-only control
Secondary metabolite Protein description
log2 fold increase
(p value)
Uniquely
detecteda Peptides
Gene IDs
(AFUA_)
Gliotoxin Unknown function protein GliH GT 3 6G09745
O-Methyltransferase GliM GT 4 6G09680
Gliotoxin thiomethyltransferase GtmA 4.2361 (0.0052) 18 2G11120
NRPS8 (unknown) NRPS8/Pes3 GT 3 5G12730
Ferricrocin NRPS involved in ferricrocin siderophore biosynthesis SidC Zn2+/GT 5 1G17200
Fumagillin Putative alpha/beta hydrolase FmaC Zn2+/GT 11 8G00380
Unknown function protein FmaD Zn2+/GT 5 8G00400
Protein encoded in the fumagillin gene cluster Zn2+/GT 10 8G00430
Putative iron-dependent oxygenase FmaF Zn2+/GT 9 8G00480
a Uniquely detected: protein uniquely identified in at least 2 biological replicates of either gliotoxin-only treated cultures or the combination
condition (Zn2+/GT).
Fig. 5 (A) Fold change in GtmA abundance following gliotoxin (GT: 15 mM)
and gliotoxin & Zn2+ (15 mM & 1 mM, respectively) exposure compared to
controls in A. fumigatus DgliT. (B) SDS-PAGE analysis of 3 independently
prepared A. fumigatus protein lysates. Lanes 1–3: negative controls:
protein lysates treated with TCEP/methanol only. Lanes 4–6: protein
lysates treated with DTG. Lanes 7–9: protein lysates treated with DTG :
Zn2+ (1 : 3). M, molecular mass marker. Protein aggregation is evident (boxes)
following DTG-exposure. (C) Number of proteins with increased or
decreased abundance (qualitative and quantitative) in aggregates recovered
from control, DTG or combined DTG/Zn2+ treatments. (D) Functional
analysis (FungiFun2) showing GO molecular function categories significantly
enriched (p o 0.05) among proteins with increased abundance in DTG-
induced aggregates. Arranged in order of ascending p value.
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lysates. Finally, it is likely that some proteins detected in the
aggregates may be present as a result of non-specific physical
entrapment, however, these putative, non-specifically aggregated
proteins are resistant to the dissolution eﬀects of SDS solubilisation
buﬀer and heat (95 1C/4 min).
Discussion
Herein, we provide evidence that DTG is a Zn2+-chelator. We
also reveal Zn2+-metalloenzyme inhibition specifically by DTG,
and not by gliotoxin or other reducing agents (DTT or GSH). This
suggests Zn2+ chelation, as well as disulphide bridge cleavage or
thiol modification, as a key mode of enzyme inhibition by DTG.
We propose that DTG, acting as a Zn2+-chelator, can significantly
inhibit growth of A. fumigatus completely deficient in essential
oxidation or thiomethylation activities. Unbiased LFQ proteomics
reveals that Zn2+ can significantly modify the nature and extent of
protein abundance alterations caused by A. fumigatus DgliT exposure
to gliotoxin. This important revelation confirms in vivo interaction
between both molecular species. Moreover, additional LFQ
proteomic data reveal that in vitro, DTG can cause specific
protein aggregation, manifested by heat instability, possibly
due to structural alteration to known Zn2+-dependent enzymes.
These unexpected observations open a new front in our exploration
of the metallo-metabolome in fungi, and possibly other species.
High resolution, negativemodeMS revealed that DTG complexes
Zn2+ and exhibits a monoisotopic peak with m/z 424.93749, which
equates to a single Zn2+[DTG] complex detected as a Cl adduct
[(DTG + 64Zn)–2H + Cl]. Previous work by Woodcock et al.
proposed the existence of a similar adduct (m/z 427), following
NaBH4-mediated reduction.
24 Since no spectra were provided, it
is not possible to ascertain the origin of the different observed
m/z values, although it seems likely that Woodcock et al. reported
the average m/z for the compound or the m/z of the base peak
[(DTG + 66Zn)–2H + Cl], rather than the monoisotopic peak.24 In
addition, we have found that DTG efficiently chelates Zn2+ from
Zn(PAR)2 (60 mM), in a dose-dependent manner from 60 to 300 mM
DTG. Given that Kocyła et al. have proposed an effective pKd of
12.15 at pH 7.4 for Zn(PAR)2, it is clear that the affinity of DTG for
Zn2+ must equate to, or exceed, this value as Zn2+ is removed from
the Zn(PAR)2 complex when equimolar amounts of DTG are added
to it.44 However, it is not ideal to compare these complexes directly
due to differences in stoichiometry. Chan et al. also deployed a PAR-
based assay system, which involved chelation of Zn2+ from Zn(PAR)2,
and subsequent formation of stable complexes to reveal that Zn2+
is chelated by dithiol holomycin (Fig. 1; termed red-holomycin
in Chan et al.) with high affinity.30 Davis et al. previously revealed
and characterised alkylation of DTG using 50-iodoacetamido-
fluorescein.45 In the present study, we observed that IAA-mediated
alkylation of DTG was inhibited by Zn2+, which further underpins
our proposal that a Zn[DTG] complex is formed via thiolate coordi-
nation and is stable under in vitro conditions used.
DTG acts as a potent inhibitor of the Zn2+-dependent enzyme,
AP. Previous studies have reported the inhibitory eﬀects of gliotoxin
on mammalian Zn2+-dependent enzymes, without attributing this
activity to zinc chelation.16,17 Vigushin et al. studied the inhibition of
Zn2+-dependent farnesyltransferase (FTase) and geranyltransferase
(GGTase) I by gliotoxin, proposing thiol modification of these
enzymes as a possible mechanism of action. Importantly, the
authors noted that these assays required the reductant DTT, which
aligns with our observations of the inhibition of Zn2+-dependent
metalloenzymes (i.e., AP) by DTG rather than gliotoxin. Our data
also provides an alternative explanation for previous observations
which suggested that reducing agents enhanced the inhibitory
activity of gliotoxin against a Zn2+-dependent equine ADH.16
Although these authors posited a redox explanation, it is equally
plausible that Zn2+ chelation by DTG eﬀected equine ADH
inhibition. This accords with our observations that prior incubation
of DTG with Zn2+ prevents inactivation of AP, and also that DTG-
associated AP inhibition can be rescued by subsequent addition
of Zn2+ (Fig. 3 and Fig. S6, ESI†).
Relevantly, it has been shown that ETPs, in particular gliotoxin,
block the interaction between Hypoxia Inducible Factor-a (HIF-a)
and the transcriptional coactivator p300 by a Zn2+ ejection
mechanism.18 Moreover, these authors noted the antiproliferative
eﬀects of ETPs, and provide significant insight into their
mechanism of action in animal cells. Cook et al. reference the
Zn2+-dependency of many gliotoxin-sensitive enzymes and the
Zn2+ requirement of GliZ, the transcription factor essential for
gliotoxin biosynthesis.1,18 However, their proposed mechanism
of action of Zn2+ ejection from p300 by gliotoxin does not take
into account the presence of DTT in assay buﬀers.18 Thus,
consequent to our observations with AP and those of Cook
et al., we now speculate that it is DTG, formed due to the
presence of equivalent amounts of DTT, and not gliotoxin per se,
which causes Zn2+ ejection from p300. Relevantly, it has recently
been elegantly demonstrated that dithiol holomycin (Fig. 1) can
eﬀect Zn2+ chelation and cause inhibition of ametallo-b-lactamase.30
Our demonstration of DTG-mediated inhibition of AP suggests that
the Zn2+ chelation potential of dithiolopyrrolones, like holomycin,
extends to ETPs.
Our deployment of A. fumigatusmutants deficient in gliotoxin
self-protection (DgliT) and self-protection/negative regulation of
gliotoxin biosynthesis in combination (DgliT::DgtmA) reveal a
hitherto unknown systems interaction between Zn2+ and gliotoxin
biochemistry. We have observed the in vitro inhibition of GtmA-
mediated BmGT formation by Zn2+. This mode of inhibition
appears to result from DTG chelation of Zn2+, and its subsequent
unavailability as a substrate to GtmA, as opposed to direct enzyme
inhibition. Interestingly, this observation is in accordance with the
eﬀect of Zn2+ (1 and 2 mM) exposure towards A. fumigatus DgliT,
whereby combinatorial gliotoxin/Zn2+ exposure significantly aug-
ments growth inhibition. In eﬀect, we postulate that elevated levels
of Zn2+ may augment intracellular Zn(DTG) complex formation,
resulting in non-availability to GtmA, which actually significantly
increases GtmA abundance (Fig. 5A). Thus, we speculate that
Zn2+-mediated disruption of GtmA functionality in A. fumigatus
DgliT partially creates an inability to dissipate DTG, though not
as absolute as pertains in A. fumigatus DgliT::DgtmA. Indeed,
A. fumigatus DgliT::DgtmA presents an ideal system to explore
the functionality of Zn2+-dependent systems in fungi, since the
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organism lacks both enzymes, GliT and GtmA, which contribute
to dissipation of intracellular DTG (Fig. 6), ultimately via either
gliotoxin or BmGT eﬄux.15 The significant, though incomplete,
Zn2+-mediated reversal of A. fumigatus DgliT::DgtmA sensitivity to
exogenous gliotoxin exposure implicates either chelation of free
Zn2+ or chelation of Zn2+ from cellular metalloenzymes, by DTG
as key inhibitory mechanisms (Fig. 6). To our knowledge, this is
the first report of an in vivo interaction between gliotoxin
biosynthesis, dysregulated DTG presence and growth inhibition
due to potential interference with Zn2+-associated growth systems.
Moreover, it contributes to explaining the cryptic observation of
Dolan et al. that A. fumigatus DgliT::DgtmA is the most gliotoxin-
sensitive mutant observed to date,15 and also why there are two
distinct enzymatic activities which can prevent intracellular DTG
accumulation. Overall, these data indicate the inhibitory potential
of this endogenous, and potent, Zn2+ chelator in A. fumigatus in
particular, and possiblymicroorganisms in general. Indeed, gliotoxin
significantly inhibits growth of a range of fungi,12,46 and previously
work has also indicated its potent anti-bacterial activity.47
It is clear that interference with intracellular DTG levels, via
gliotoxin exposure to A. fumigatus DgliT impacts on the fungal
proteome, which in turn can be modulated by Zn2+ presence.
Indeed, it has been estimated that up to 6% (600/10000) of
the A. fumigatus proteome comprises Zn2+-binding proteins;
interestingly, this includes a prediction of 300 Zn2+ finger
transcription factors.48 Relevantly, co-addition of gliotoxin
and Zn2+ induced key alterations to abundance of proteins
involved in secondary metabolism. Proteins from the gliotoxin
biosynthetic cluster, GliM and GliH, were uniquely detected in
mycelia exposed to gliotoxin, indicating that combinatorial
exposure with Zn2+ prevents activation of gliotoxin cluster
expression. While GliM and GliH are induced in response to
gliotoxin, these proteins are not detected following BmGT
exposure.9 This may implicate Zn2+ chelation in the activation
of the gliotoxin transcription factor GliZ and the induction of
cluster expression. O’Keeﬀe et al. noted gliotoxin exposure
suppresses fumagillin cluster expression in A. fumigatus DgliT.14
This result was reflected in the current study, however co-exposure
to gliotoxin and Zn2+ reversed this eﬀect, leading to unique
detection of fumagillin biosynthetic proteins. As with gliotoxin,
the fumagillin cluster is also regulated by a (Zn2+)2Cys6 transcription
factor (FapR/FumR),49,50 possibly implicating Zn2+ chelation
in cluster repression, since exogenous Zn2+ blocks gliotoxin-
associated repression. These proteomic observations are supported
by the switch from gliotoxin to fumagillin production in A. fumigatus
upon Zn2+ supplementation (Fig. S10, ESI†).
Incubation of A. fumigatus protein lysates with DTG prior to
heat treatment resulted in increased protein aggregation, compared
to the solvent control. Oxidoreductases, metal-binding proteins and
zinc-binding proteins were significantly enriched amongst these
DTG-aﬀected proteins (p o 0.05). DTG-induced aggregation of
zinc-binding proteins including two alcohol dehydrogenases,
AlcC and AFUA_1G04620, and the farnesyltransferase (AFUA_
4G10330) was observed. This is in line with observed inhibition
of mammalian homologs of these proteins by gliotoxin in
reducing conditions.16,17 AlcC was also observed to increase in
abundance in vivo when A. fumigatus DgliT was treated with a
combination of gliotoxin and Zn2+ compared to gliotoxin alone
(Table S1, ESI†), possibly to compensate for loss of activity. AlcC
has been identified as the primary hypoxia-responsive ADH in
A. fumigatus, with a potential role in pathogenesis,51 while
farnesyltransferase has a role in signalling and also contributes
to disease.52 Further investigation could elucidate the eﬀect
of DTG on the functionality of these proteins in A. fumigatus.
Pre-incubation of DTG with excess Zn2+ abrogated this eﬀect,
most likely through formation of Zn(DTG) complexes prior to
addition to protein lysates, leading to reduced levels of protein
aggregation. A number of metallopeptidases (AFUA_6G09190,
AFUA_4G07910, AFUA_1G14920 and MepB) were also observed
to undergo increased aggregation in response to DTG, while this
was prevented in the presence of Zn2+. These peptidases contribute
to protein modification and degradation, and so alteration of
these processes by DTG has the potential to disrupt protein
turnover. Interestingly, gliotoxin has previously been implicated
in inhibition of proteolytic activity of human and toxoplasma
proteasomes.53,54 The cobalamin-independent methionine
synthase MetH/D showed a similar response to DTG treatment,
with Zn2+ co-addition blocking aggregation. MetH/D contains a
zinc-binding site, required for binding and activation of its
substrate homocysteine.55 DTG-mediated aggregation of MetH/D
would interrupt an integral part of primary metabolism and
potentially aﬀect pathogenesis.56 Interestingly, while metH/D
showed no response to gliotoxin in A. fumigatus wild-type,
expression was significantly induced in A. fumigatus DgliT in
response to gliotoxin.14 Persistence of intracellular DTG, in the
Fig. 6 Overview of the proposed mechanism and consequences of Zn2+
chelation by intracellular DTG in A. fumigatus. DTG is produced consequent
to gliotoxin uptake, via GSH-mediated chemical reduction, or de novo
gliotoxin biosynthesis. Under normal conditions, two enzyme systems,
namely GliT-mediated oxidation and GtmA-mediated thiomethylation eﬀect
dismutation of DTG to prevent interference with intracellular zinc homeostasis.
In the absence of both enzymes, elevated intracellular DTG can either chelate
free Zn2+ or chelate it from intracellular Zn2+-dependent metalloenzymes,
causing extreme growth inhibition. Additionally, Zn(DTG) cannot be converted
to BmGT via GtmA. Either way, disruption of intracellular zinc homeostasis
occurs which leads to activation of zinc uptake systems, potentially via ZafA
induction of ZrfA-C expression.
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absence of GliT-mediated oxidation, results in disruption of the
methionine cycle, with SAM depletion caused by dysregulation of
gliotoxin methylation.8 Added to the extensive SAM consumption,
DTG-associated destabilisation of methionine synthase through
Zn2+-chelation could place an additional strain on the methionine
cycle in A. fumigatus DgliT. While further studies are required to
confirm if these proteins are directly aﬀected by DTG in vivo, these
results present strong targets for future investigations to elucidate
the systemic eﬀect of DTG on A. fumigatus. Of course, Zn2+
chelation is likely not the only mechanism by which DTG exerts
its eﬀects on the cell, with previous studies illustrating its potential
for thiol modification and redox reactions.57,58 This methodology
also provides an unbiased discovery-based mechanism allowing
for the identification of putative targets of DTG in other complex
systems.
Interestingly, Mu¨ller et al. have shown that allicin (diallyl
thiosulphinate) can cause thiol stress and severe growth inhibition
in bacteria.59 Specifically, Muller et al. revealed that allicin induced
protein aggregation, likely due to S-allylmercapto protein modifi-
cation, in crude Escherichia coli cell lysates in a concentration-
dependent manner. This is in accordance with our observations of
DTG-induced protein aggregation in A. fumigatus protein lysates,
although fungal protein destabilisation possibly involves Zn2+
chelation mechanism, as opposed to protein modification. Future
work will clarify the relative contribution of either mechanism.
As can be seen in Fig. S8 (ESI†), gliotoxin addition to
A. fumigatus results in uptake, followed by conversion to intra-
cellular DTG and induction/augmentation of gliotoxin biosynthesis,
as previously reported in Owens et al. and Dolan et al.8,15 Based on
our new observations, we now extend this model and provide a
mechanistic link between the intracellular presence of DTG and
(i) Zn2+ depletion leading to increased ZrfB abundance, as well as
(ii) potential Zn2+ chelation and destabilisation of metallo-
enzymes. Interestingly, the membrane-permeable zinc chelator,
TPEN, which has been used in vivo60 and in A. fumigatus
studies,61 demonstrated lower AP inhibition than DTG (Fig. 3).
The dissociation constant (Kd) of Zn(TPEN) has been reported as
6.4  1016 M (pKd 15.2) at pH 7.4, with the same 1 : 1 stoichio-
metry as the Zn(DTG) complex.62,63 Future studies will quantify
the aﬃnity of DTG for Zn2+ however, considering DTG caused
significantly greater AP inhibition than TPEN, it is reasonable to
conclude that DTG is a better Zn2+ chelator than TPEN under the
conditions tested. TPEN has been shown to act co-operatively with
the antifungal drug caspofungin to significantly improve survival
in a mouse model system of Invasive Pulmonary Aspergillosis
compared to either caspofungin or TPEN administration alone.64
This exciting development is important because exposure to
combinations of antifungal drugs, acting in synergy, may address
both the development of pathogen resistance and toxicity of high
therapeutic levels of either drug alone to the recipient. Although
TPEN administration may not have any immediate harmful
eﬀects in animals, its safety profile following co-administration
with antifungal drugs is unknown. Our observation of DTG as
an intracellular Zn2+ chelator, ideally positions it as a potential
endogenous anti-fungal, especially if strategies to interfere with
its enzymatic elimination are elucidated in future research.
Conclusions
Overall, new in vivo and in vitro interactions between Zn2+ and
DTG, with multiple biological consequences, are revealed.
A. fumigatus is a pathogen for which limited therapeutic options
exist. Although much recent work has greatly increased the
understanding of this and other fungal species, investigation of
cryptic interaction between Zn2+ and BGC-encoded metabolite
functionality needs urgent study. Any new systems identified
could not only represent antifungal drug targets, but also inform
on the exploitation of BGC-encoded, dithiol-containing, meta-
bolites to restrict Zn2+ availability in many microbial species.
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